Karen Pendergrass is a microbiome researcher specializing in microbiome-targeted interventions (MBTIs). She systematically analyzes scientific literature to identify microbial patterns, develop hypotheses, and validate interventions. As the founder of the Microbiome Signatures Database, she bridges microbiome research with clinical practice. In 2012, based on her own investigative research, she became the first documented case of FMT for Celiac Disease—four years before the first published case study.
2024-02-22 20:17:17
Microbiome Signatures Definition: A Conceptual Advancement for Translational Microbiome ScienceMicrobiome signatures are reproducible ecological and functional patterns—encompassing traits, interactions, and metabolic functions—that reflect microbial adaptation to specific host or environmental states. Beyond taxonomy, they capture conserved features like metal metabolism or immune modulation, enabling systems-level diagnosis and intervention in health and disease.
2024-02-20 11:34:03
Your Unique Microbiome SignatureYour microbiome is the collection of microorganisms (such as bacteria, fungi, and viruses) that live on and in your body. It is unique to you and can be influenced by various factors, including your diet, environment, and genetics. Determining your own unique Microbiome Signature can be performed by undergoing microbiome testing. This can be done […]
2024-01-29 19:21:34
PhotobiomodulationPhotobiomodulation (BM), formerly known as Level Laser Therapy (LLT), is a non-invasive therapeutic technique involving the application of light, typically in the red to near-infrared (IR) spectrum, to promote tissue repair, reduce inflammation and pain, and provide various other therapeutic effects. This technique has gained significant attention in clinical and research settings due to its […]
2024-01-01 00:00:00
Profiles of subgingival microbiomes and gingival crevicular metabolic signatures in patients with amnestic mild cognitive impairment and Alzheimer’s disease2024-01-01 00:00:00
Gut microbiome is not associated with mild cognitive impairment in Parkinson’s disease2024-01-01 00:00:00
Meta-analysis of shotgun sequencing of gut microbiota in Parkinson’s disease2024-01-01 00:00:00
Metagenome-assembled microbial genomes from Parkinson’s disease fecal samples2024-01-01 00:00:00
Oral and gut microbiome profiles in people with early idiopathic Parkinson’s disease2024-01-01 00:00:00
Oral, Vaginal, and Stool Microbial Signatures in Patients With Endometriosis as Potential Diagnostic Non-Invasive Biomarkers: A Prospective Cohort StudyThis study explores oral, vaginal, and stool microbial signatures in patients with endometriosis, highlighting their potential as non-invasive diagnostic biomarkers. Findings suggest distinct microbial shifts in these sites, offering a promising avenue for early detection and targeted intervention in endometriosis management.
2024-01-01 00:00:00
Breast cancer but not the menopausal status is associated with small changes of the gut microbiota